COSM Cosmos Health Inc.

Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.

Cosmos Health Inc.

Recent Analyst Ratings for Cosmos Health Inc.

Cosmos Health Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Siokas Grigorios bought $15,217 worth of shares (34,004 units at $0.45), increasing direct ownership by 0.56% to 6,158,884 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $62,800 worth of shares (141,825 units at $0.44), increasing direct ownership by 2% to 6,124,880 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $82,000 worth of shares (174,172 units at $0.47), increasing direct ownership by 3% to 5,983,055 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $65,961 worth of shares (147,563 units at $0.45), increasing direct ownership by 3% to 5,808,883 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $34,000 worth of shares (79,254 units at $0.43), increasing direct ownership by 1% to 5,661,320 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $102,000 worth of shares (254,618 units at $0.40), increasing direct ownership by 5% to 5,582,066 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $71,000 worth of shares (177,234 units at $0.40), increasing direct ownership by 3% to 5,327,448 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $82,000 worth of shares (205,000 units at $0.40), increasing direct ownership by 4% to 5,150,214 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $63,000 worth of shares (175,000 units at $0.36), increasing direct ownership by 4% to 4,945,214 units (SEC Form 4)

Chief Executive Officer Siokas Grigorios bought $208,000 worth of shares (654,912 units at $0.32), increasing direct ownership by 16% to 4,770,214 units (SEC Form 4)